Four shots to fight the fever

Mon. June 16, 2008; Posted: 09:50 PM

7 Stocks You Need To Know For Tomorrow -- Free Newsletter

Jun 16, 2008 (New Scientist - ABIX via COMTEX) -- AGYTF | Quote | Chart | News | PowerRating -- A company in the UK has developed a vaccine to alleviate hayfever symptoms. Sufferers of hayfever are allergic to pollen and get sore eyes, runny noses and prolonged bouts of sneezing. Allergy Therapeutics, in Worthing, UK, created the vaccine, called Pollinex Quattro. The company tested over 1,000 volunteers with the vaccine and a placebo for the control group just before the 2007 hayfever season. During the peak hayfever period, symptoms in those injected with the vaccine were reduced by 13%. The vaccine requires four injections over four weeks, making it quick and easy. Allergy Therapeutics wants to apply for permission to sell the vaccine in Europe in 2009.

Publication Date: 7 June 2008

ALLERGY THERAPEUTICS PLC UNITED STATES. FOOD AND DRUG ADMINISTRATION GLAXOSMITHKLINE PLC

For full details for AGYTF click here.

Morning Coffee with TradingMarkets -- Free Newsletter

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.